UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection

Bodda, C; Reinert, LS; Fruhwürth, S; Richardo, T; Sun, C; Zhang, B-C; Kalamvoki, M; ... Paludan, SR; + view all (2020) HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection. Journal of Experimental Medicine , 217 (7) , Article e20191422. 10.1084/jem.20191422. Green open access

[thumbnail of jem_20191422.pdf]
Preview
Text
jem_20191422.pdf - Accepted Version

Download (4MB) | Preview

Abstract

Herpes simplex virus (HSV) is the main cause of viral encephalitis in the Western world, and the type I interferon (IFN) system is important for antiviral control in the brain. Here, we have compared Ifnb induction in mixed murine brain cell cultures by a panel of HSV1 mutants, each devoid of one mechanism to counteract the IFN-stimulating cGAS–STING pathway. We found that a mutant lacking the deubiquitinase (DUB) activity of the VP1-2 protein induced particularly strong expression of Ifnb and IFN-stimulated genes. HSV1 ΔDUB also induced elevated IFN expression in murine and human microglia and exhibited reduced viral replication in the brain. This was associated with increased ubiquitination of STING and elevated phosphorylation of STING, TBK1, and IRF3. VP1-2 associated directly with STING, leading to its deubiquitination. Recruitment of VP1-2 to STING was dependent on K150 of STING, which was ubiquitinated by TRIM32. Thus, the DUB activity of HSV1 VP1-2 is a major viral immune-evasion mechanism in the brain.

Type: Article
Title: HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1084/jem.20191422
Publisher version: https://doi.org/10.1084/jem.20191422
Language: English
Additional information: This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/)
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases
URI: https://discovery.ucl.ac.uk/id/eprint/10098429
Downloads since deposit
45Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item